Macrogenics (MGNX) Operating Leases (2019 - 2026)
Macrogenics (MGNX) reported Operating Leases of $31.3 million for Q1 2026, down 2.5% year-over-year from $32.1 million in Q1 2025, and down 0.92% quarter-over-quarter from $31.6 million in Q4 2025.
Macrogenics (MGNX) Operating Leases (2019 - 2026) Analysis & Trends
Macrogenics (MGNX) has 8 years of Operating Leases data on file, last reported at $31.3 million in Q1 2026.
- Operating Leases for Q1 2026 came in at $31.3 million, down 2.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.3 million (down 2.5% YoY), and the FY2025 annual result was $31.6 million, down 3.1% from the prior year.
- Operating Leases fell to $31.3 million in Q1 2026 per MGNX's latest filing, from $31.6 million in the prior quarter.
- Over five years, Operating Leases peaked at $32.6 million in Q4 2024 and troughed at $17.0 million in Q3 2022.
- A 5-year average of $28.6 million and a median of $30.2 million in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2023: Operating Leases slipped 22.81% in 2022, then jumped 77.54% in 2023.
- A 5-year view of Operating Leases shows it stood at $30.1 million in 2022, then increased by 0.3% to $30.2 million in 2023, then grew by 7.95% to $32.6 million in 2024, then retreated by 3.1% to $31.6 million in 2025, then slipped by 0.92% to $31.3 million in 2026.
- Business Quant data shows MGNX's Operating Leases at $31.3 million in Q1 2026, $31.6 million in Q4 2025, and $31.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.30 Mn |
| Dec 31, 2025 | 31.59 Mn |
| Sep 30, 2025 | 31.87 Mn |
| Jun 30, 2025 | 32.13 Mn |
| Mar 31, 2025 | 32.10 Mn |
| Dec 31, 2024 | 32.60 Mn |
| Sep 30, 2024 | 29.36 Mn |
| Jun 30, 2024 | 29.65 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 30.20 Mn |
| Sep 30, 2023 | 30.18 Mn |
| Jun 30, 2023 | 30.16 Mn |
| Mar 31, 2023 | 30.13 Mn |
| Dec 31, 2022 | 30.11 Mn |
| Sep 30, 2022 | 17.00 Mn |
| Jun 30, 2022 | 18.26 Mn |
| Mar 31, 2022 | 19.51 Mn |
| Dec 31, 2021 | 20.79 Mn |
| Sep 30, 2021 | 22.03 Mn |
| Jun 30, 2021 | 23.21 Mn |